Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria

被引:80
作者
Meerman, L
Koopen, NR
Bloks, V
van Goor, H
Havinga, R
Wolthers, BG
Kramer, W
Stengelin, S
Müller, M
Kuipers, F
Jansen, PLM
机构
[1] Univ Groningen Hosp, Dept Pediat, Ctr Liver Digest & Metab Dis, NL-9700 RB Groningen, Netherlands
[2] Groningen Inst Drug Studies, Ctr Liver Digest & Metab Dis, Groningen, Netherlands
[3] Univ Groningen Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, NL-9700 RB Groningen, Netherlands
[4] Univ Groningen Hosp, Dept Pathol, NL-9700 RB Groningen, Netherlands
[5] Univ Groningen Hosp, Cent Clin Lab, NL-9700 RB Groningen, Netherlands
[6] Hoechst Marion Roussel, Frankfurt, Germany
关键词
D O I
10.1016/S0016-5085(99)70464-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Reduced activity of ferrochelatase in erythropoietic protoporphyria (EPP) results in protoporphyrin (PP) accumulation in erythrocytes and liver. Liver disease may occur in patients with EPP, some of whom develop progressive liver failure that necessitates transplantation. We investigated the mechanisms underlying EPP-associated liver disease ina mouse model of EPP. Methods: Liver histology, indicators of lipid peroxidation, plasma parameters of liver function, and bile composition were studied in mice homozygous (fch/fch) for a point mutation in the ferrochelatase gene and in heterozygous (fch/+) and wild-type (+/+) mice. Results: Microscopic examination showed bile duct proliferation and biliary fibrosis with portoportal bridging in fch/fch mice. PP content was 130-fold increased, and thiobarbituric: acid-reactive substances (+30%) and conjugated dienes (+75%) were slightly higher in fch/fch than in fch/+ and +/+ livers. Levels of hepatic thiols (-12%) and iron (-52%) were reduced in fch/fch livers. Liver enzymes and plasma bilirubin were markedly increased in the homozygotes. Plasma bile salt levels were 80 times higher in fch/fch than in fch/+ and +/+ mice, probably related to the absence of the Nac-taurocholate cotransporting protein (Ntcp) in fch/fch liver. Paradoxically, bile flow was not impaired and biliary bile salt secretion was 4 times higher in fch/fch mice than in controls. Up-regulation of the intestinal Na+-dependent bile salt transport system in fch/fch mice may enhance efficiency of bile salt reabsorption. The bile salt/lipid ratio and PF content of fch/fch bile were increased 2-fold and 85-fold, respectively, compared with +/+, whereas biliary glutathione was reduced by 90%, Similar effects on bile formation were caused by griseofulvin-induced inhibition of ferrochelatase activity in control mice. Conclusions: Bile formation is strongly affected in mice with impaired ferrochelatase activity. Rather than peroxidative processes, formation of cytotoxic bile with high concentrations of bile salts and PP may cause biliary fibrosis in fch/fch mice by damaging bile duct epithelium.
引用
收藏
页码:696 / 705
页数:10
相关论文
共 45 条
  • [1] Functional expression of the apical Na+-dependent bile acid transporter in large but not small rat cholangiocytes
    Alpini, G
    Glaser, SS
    Rodgers, R
    Phinizy, JL
    Robertson, WE
    Lasater, J
    Caligiuri, A
    Tretjak, Z
    LeSage, GD
    [J]. GASTROENTEROLOGY, 1997, 113 (05) : 1734 - 1740
  • [2] AVNER DL, 1982, J LAB CLIN MED, V99, P885
  • [3] MECHANISM OF BILE-ACID FACILITATION OF BILIARY PROTOPORPHYRIN EXCRETION IN RAT-LIVER
    BERENSON, MM
    ELMIR, MY
    ZHANG, LK
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1995, 268 (05): : G754 - G763
  • [4] EFFECT OF BILE-ACID HYDROXYLATION ON BILIARY PROTOPORPHYRIN EXCRETION IN RAT-LIVER
    BERENSON, MM
    MARIN, JJG
    GUNTHER, C
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 255 (03): : G382 - G388
  • [5] Relationship between biliary lipid and protoporphyrin secretion; Potential role of mdr2 P-glycoprotein in hepatobiliary organic anion transport
    Beukeveld, GJJ
    Veld, GI
    Havinga, R
    Groen, AK
    Wolthers, BG
    Kuipers, F
    [J]. JOURNAL OF HEPATOLOGY, 1996, 24 (03) : 343 - 352
  • [6] BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
  • [7] Molecular defects in ferrochelatase in patients with protoporphyria requiring liver transplantation
    Bloomer, J
    Bruzzone, C
    Zhu, L
    Scarlett, Y
    Magness, S
    Brenner, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (01) : 107 - 114
  • [8] FERROCHELATASE STRUCTURAL MUTANT (FECH(M1PAS)) IN THE HOUSE MOUSE
    BOULECHFAR, S
    LAMORIL, J
    MONTAGUTELLI, X
    GUENET, JL
    DEYBACH, JC
    NORDMANN, Y
    DAILEY, H
    GRANDCHAMP, B
    DEVERNEUIL, H
    [J]. GENOMICS, 1993, 16 (03) : 645 - 648
  • [9] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [10] Erythropoietic protoporphyria
    Cox, TM
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 1997, 20 (02) : 258 - 269